Novel concept in the mechanism of injury and protection of gastric mucosa: Role of renin-angiotensin system and active metabolites of angiotensin

Current Medicinal Chemistry

Volumn 19, Issue 1, 2012, Pages 55-62

  Brzozowski, T ^a   Ptak Belowska, A ^a   Kwiecien, S ^a   Krzysiek Maczka, G ^a   Strzalka, M ^a   Drozdowicz, D ^a   Pajdo, R ^a   Olszanecki, R ^a   Korbut, R ^a   Konturek, S J ^a   Pawlik, W W ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Angiotensin (1 7); Gastric blood flow; Gastric protection; Mas receptor; Nitric oxide; Prostaglandin; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN II; BRADYKININ; ENDOTHELIUM DERIVED RELAXING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NITRIC OXIDE; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; TELMISARTAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CELL PROTECTION; CHEMICAL STRUCTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; GASTRITIS; GENE EXPRESSION; HUMAN; HYPERTENSION; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; METABOLITE; MICROCIRCULATION; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH INJURY; STOMACH MUCOSA; STOMACH ULCER; STRESS; VASOCONSTRICTION; VASODILATATION; WATER RETENTION;

EID: 84857546554     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803413953     Document Type: Article

References (96)

1. Davenport, H.W.; Warner, H.A.; Code, C.F. Functional significance of gastric mucosal barrier to sodium. Gastroenterology, 1968, 4, 709-11.
2. Robert, A.; Nezamis, J.E.; Lancaster, C.; Hanchar, A.J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenteroligy, 1979, 77, 433-440.
3. Konturek, S.J.; Piastucki, I.; Brzozowski, T.; Radecki, T.; Dembinska-Kiec, A.; Zmuda, A.; Gryglewski, R. Role of prostaglandins in the formation of aspirin induced gastric ulcers. Gastroenterology, 1981, 80, 4-9. (Pubitemid 11213280)
4. Konturek, S.J.; Radecki, T.; Brzozowski, T.; Piastucki, I.;, Dembinska-Kiec, A.; Gryglewski, R.Prostaglandin E2 in gastric mucosa and its role in the prevention of ulcers induced by acetyl salicylic acid in cats. Digestion, 1981, 21, 205-213 (Pubitemid 11183916)
5. Svanes, K.; Gislason, H.; Guttu, K.; Herfjord, J.K.; Fevang, J.; Gronbech, J.E. Role of blood flow in adaptive protection of the cat gastric mucosa. Gastroenterology, 1991, 100, 1249-1258.
6. Terano, A.; Mach, T.; Stachura, J.; Tarnawsk, A.; Ivey, K.J. Effect of 16,16 dimethyl prostaglandin E2 on aspirin induced damage to rat gastric epithelial cells in tissue culture. Gut, 1984, 25, 19-25. (Pubitemid 14125742)
7. Tarnawski, A.; Brzozowski, T.; Sarfeh, J.; Krause, W.J.; Ulich, T.R.; Gergely, H.; Hollander, D. Prostaglandin protection of human isolated gastric glands against indomethacin and ethanol injury. Evidence for direct cellular action of prostaglandin. J. Clin. Invest., 1998; 81, 1081-1089.
8. Brzozowski, T.; Tarnawski, A.; Hollander, D.; Sekhon, S.; Krause, W.J.; Gergely, H. Comparison of prostaglandin and cimetidine in protection of isolated gastric glands against indomethacin injury. J. Physiol. Pharmacol ., 2005, 56, 5: 75-88.
9. Konturek, S.J.; Brzozowski, T.; Majka, J.; Dembinski, A.; Sńomiany, A.; Sńomiany, B.L. Transforming growth factor and epidermal growth factor in protection and healing of gastric mucosal injury. Scand. J. Gastroenterol., 1992, 27, 649-655
10. Robert, A.; Nezamis, I.E.; Lancaste,r C.; Davies, I.P.; Field, S.O.; Hanchar, A.J. Mild irritant prevent gastric necrosis through adaptive cytoprotection mediated by prostaglandins. Am J Physiol 1983, 245: 113-116.
11. Konturek, S.J.; Brzozowski, T.; Piastucki, I.; Dembinski, A.; Dembinska-Kiec, A. Role of locally generated prostaglandin in adaptive gastric cytoprotection, Dig. Dis. Sci., 1982, 27: 967-77.
12. Cho, C.H.; Ko, I.K.; Tang, X.L. The differential mechanism of mild irritants on adaptative cytoprotection. Eur. J. Gastroenterol. Hepatol., 1994, 9,1, 24.
13. Mutoh, H.; Ota, S.; Hiraishi, H.; Ivey, K.J.; Terano, A.; Sugimoto, T.; Adaptive cytoprotection in cultured rat gastric mucus-producing cells. Role of mucus and prostaglandin synthesis. Dig. Dis. Sci., 1995; 40, 872-878.
14. Lacy, E.;R, Ito, S. Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology, 1982, 83, 619-625. (Pubitemid 12096934)
15. Tarnawski, A.; Hollander D, Stachura J, Krause WJ, Gergely H. Prostaglandin protection of the gastric mucosa against alcohol injury -a dynamic time related process. Role of the mucosal proliferative zone. Gastroenterology, 1985, 88: 334-52. (Pubitemid 15224613)
16. Konturek, S.;J, Brzozowski, T.; Pytko-Polonczyk, J.; Drozdowicz, D. Exogenous and endogenous cholecystokinin protects gastric mucosa against the damage caused by ethanol in rats. Eur. J. Pharmacol., 1995, 273: 57-62.
17. Konturek, S.J.; Brzozowski, T.; Bielanski, W.; Schally, A.V. Role of endogenous gastrin in gastroprotection. Eur J Pharmacol 1995, 278, 203-212.
18. Brzozowski, T. Konturek, P.Ch.; Pajdo, R.; Duda, A.; Pierzchalski, P.; Bielanski, W. et al. Leptin in gastroprotection induced by cholecystokinin or by a meal. Role of vagal and sensory nerves and nitric oxide. Eur. J. Pharmacol., 1999, 374:263-276. (Pubitemid 29287142)
19. Sibilia, V.; Rindi, G.; Pagani, F. et al. Ghrelin protects against ethanolinduced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology, 2003, 144: 353-9. (Pubitemid 36076125)
20. Brzozowski, T., Konturek, P.C.; Konturek, S.J.; Kwiecien, S.; Drozdowicz, D.; Bielanski, W.; Pajdo, R.; Ptak, A.; Nikiforuk, A.; Pawlik, W.W.; Hahn, E.G. Exogenous and endogenous ghrelin in gastroprotection against stressinduced gastric damage. Reg. Pept., 2004, 120: 39-51. (Pubitemid 38726190)
21. Brzozowski, T.; Konturek, P.C.; Sliwowski, Z.; Pajdo, R.; Drozdowicz, D.; Kwiecień, S.; Burnat, G.; Konturek, S.J.; Pawlik, W.W. Prostaglandin/cyclooxygenase pathway in ghrelin-induced gastroprotection against ischemia-reperfusion injury. J. Pharmacol. Exp. Ther ., 2006,319, 1:477-87.
22. Tigerstedt, R.; Bergman, P.G. Niere und Kreislauf. Scand. Arch. Physiol., 1898, 4, 223-271.
23. Skrbic, R.; Igic, R.; Seven decades of angiotensin (1939-2009). Peptides, 2009, 30, 1945-1950.
24. Griendling, K.K.; Lassègue, B.; Alexander, R.W. Angiotensin receptors and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol., 1996, 36, 281-306. (Pubitemid 26169900)
25. Paul, M.; Poyan, Mehr, A.; Kreutz. R.; Physiology of local renin-angiotensin systems. Physio.l Rev., 2006, 86,3,747-803. (Pubitemid 44033382)
26. Heinemann, A.; Sattler, V.; Jocic, M.; Wienen, W.; Holzer, P. Effect of angiotensin II and telmisartan, an angiotensin1 receptor antagonist, on gastric mucosal blood flow. Aliment. Pharmacol. Ther. 1999, 13, 347-355. (Pubitemid 29142044)
27. Lavoie, J.L.; Sigmund, C.D. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology, 2003, 144,6, 2179-2183. (Pubitemid 36629863)
28. Suzuki, Y.; Ruiz-Ortega, M.; Lorenzo, O.; Ruperez, M.; Esteban, V.; Egido, J. Inflammation and angiotensin II. Int. J. Biochem. Cell. Biol .,2003, 35,6, 881-900. (Pubitemid 36379329)
29. Deshayes, F.; Nahmias, C. Angiotensin receptors: a new role in cancer?. Trends. Endocrinol. Metab., 2005, 16,7, 293-299. (Pubitemid 41206635)
30. Ishiyama, Y.; Gallagher, P.E.; Averill, D.B.; Tallant, E.A.; Brosnihan, K.B.; Ferrario, C.M.; Upregulation of angiotensin converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension, 2004, 43,5. 970-976. (Pubitemid 38579900)
31. Xu, F.; Mao, C.; Rui, C.; Xu, Z.; Zhang, L. Cardiovascular Effects of Losartan and Its Relevant Clinical Application. Curr. Med. Chem., 2009, 13.
32. Saavedra, J.M.; Sanchez -Lemus E.; Benicky, J. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoendocrinology, 2011, 36, 1-18.
33. Kaparianos, A.; Argyropoulou, E. Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome. Curr. Med. Chem. 2011, 14.
34. Lee, M.;A, Bohm, M.; Paul, M.; Ganten, D. Tissue renin angiotensin systems. Their role in cardiovascular disease. Circulation, 1993, 87, 5, 13.
35. Sechi, L.A.; Valentin, J.P.; Griffin, C.A.; Schambelan, M. Autoradiographic characterization of angiotensin II receptor subtypes in rat intestine. Am. J. Physio.l Gastrointest. Liver. Physiol., 1993, 265, G21-G27. (Pubitemid 23223083)
36. Bregonzio, C.; Armando, I.; Ando, H. et al. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am. J. Physiol.Gastrointest. Live.r Physiol., 2003, 285:G414.
37. Nakagiri, A.; Sunamoto, M.; Murakami, M. Angiotensin AT1 receptor blockers suppress ischemia/reperfusion-induced gastric injury in rats. Inflammopharmacology, 2007, 15,4,171-174. (Pubitemid 47262714)
38. Okuda, T.; Yoshida, N.; Takagi, T.; Handa, O.; Kokura, S.; Ichikawa, H.; Naito, Y.; Yoshikawa, T. CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis. Dig. Dis. Sci., 2008, 53,3, 657-663. (Pubitemid 351320497)
39. Riaz, A,A.; Wang, Y.; Schramm, R. et al. Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. Faseb. J. 2004,18,881.
40. Takagi, T.; Yoshida, N.; Isozaki, Y. et al. CV-11974, angiotensin II type I receptor antagonist, protects against ischemia-reperfusion injury of the small intestine in rats. Eur. J. Pharmacol. 2006, 535,283.
41. Sendur, R.; Biernat, R.; Pawlik, M.; Obuchowicz, R.; Pawlik, W.W. Role of angiotensin 1-7 in the mediation of gastric circulatory and protective action angiotensin converting enzyme inhibitor. Faseb J., 2005, 19, 4, A74.
42. Brzozowski, T.; Konturek,; P,C.; Konturek, S.J, et al. Expression of cyclooxygenase (COX)-1 and COX-2 in adaptive cytoprotection induced by mild stress. J. Physiol. Paris., 2000, 94:83.
43. Brzozowski, T.; Konturek, P.C.; Pajdo, R. et al. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins. J. Physiol. Pharmacol., 2008, 59,2, 89.
44. Senay, C.E.; Levine, R.J. Synergism between cold and restraint for rapid production of stress ulcer in rats. Proc. Soc. Exp. Biol. Med., 1967, 124, 1221-1223.
45. Jezova, D.; Ochedalski, T.; Kiss, A.; Aguilera, G. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J. Neuroendocrinol., 1998, 10, 67-72. (Pubitemid 28055040)
46. Suzuki, Y.; Ruiz-Ortega, M.; Lorenzo, O. et al. Inflammation and angiotensin II. Int. J. Biochem. Cell. Biol., 2003, 35,881.
47. Ruiz-Ortega, M.; Lorenzo, O.; Suzuki, Y. et al. Proinflammatory actions of angiotensins. Cur. Opin. Nephrol. Hypertens., 2001, 10:321.
48. Marchesi, C. ; Paradis, P. ; Schiffrin, E.L. Role of the renin-angiotensin system in vascular inflammation. Trends. Pharmacol. Sci., 2008, 29:367.
49. Nishimura, Y.; Ito, T.; Hoe, K.L.; Saavedra, J.M. Chronic peripheral administration of the angiotensin II AT1 receptor antagonist candesartan blocks brain AT1 receptors. Brain. Res., 2000, 871: 29-38 (Pubitemid 30406864)
50. Zhang, Y.M.; Wei, E.Q.; Hu. X. et al. The role of nuclear factor-αB in the effect of angiotensin II in the paraventricular nucleus in protecting the gastric mucosa from ischemia-reperfusion injury in rats. J. Gastroenterol., 2008, 43:687.
51. Gemici, B.; Tan, R.; Ongut, G.; Izgut-Uysal N. Expressions of inducible nitric oxide synthase and cyclooxygenase -2 in gastric ischemia -reperfusion: role of angiotensin II. J. Surg. Res., 2009, 6, 1-8.
52. Ito, T.; Yamakawa, H.; Bregonzio, C.; Terrón, J.A.; Falcón-Neri, A.; Saavedra, J.M.; Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke, 2002, 33, 2297-2303. (Pubitemid 35014646)
53. Carl-McGrath, S.; Grantzdorffer, I.; Lendeckel, U.; Ebert, M.P.; Rocken, C. Angiotensin II -generating enzymes, angiotensin-converting enzyme (ACE) and mast cell chymase (CMA1), in gastric inflammation may be regulated by H.pylori and associated cytokines. Pathology, 2009, 41, 419-427.
54. Hasegawa, G.; Fukui, M.; Hosada, H.; Asano, M.; Harusato, I.; Tanaka, M.; Shiraishi, E.; Senmaru, T.; Sakabe, K.; Yamasaki, M.; Kitawaki, J.; Fujinami, A.; Ohta, M.; Obayashi, H.; Nakamura, N. Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spont aneously Diabetic Torii rats. Eur. J. Pharmacol., 2009, 605, 164-169.
55. Cai, H.; Griendling, K.K.; Harrison, D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends. Pharmacol. Sci., 2003, 24:,471-478. (Pubitemid 37088172)
56. Nakagiri, A.; Sunamoto, M.,;Takeuchi, K.; Murakami, M. Evidence for the involvement of NADPH oxidase in ischemia/reperfusion-induced gastric damage via angiotensin II. J. Physiol. Pharmacol., 2010, 61, 2, 171-9.
57. Gao, Y.; Zhou, S.; Wen, J.; Huang, M.; Xu, A. Mechanism of the antiulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat. Life Sci., 2002, 72, 731-745. (Pubitemid 35446315)
58. Zhang, X.; Tajima, K.; Kageyama, K.; Kyoi, T. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats. World J. Gastroenterol., 2008, 14, 4784-4790.
59. Benson, S.C.; Pershadsingh, H.A.; Ho, C.I, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, Kurtz TW. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity. Hypertension, 2004, 43, 993-1002. (Pubitemid 38579904)
60. Nakamura, T.; Keep, R.F.; Hua, Y. Hoff, J.T.; Xi, G. Oxidative DNA injury after experimental intracerebral hemorrhage. Brain Res., 2005, 1039-36.
61. Blessing, E.; Preusch, M.; Kranzhöfer, R.; Kinscherf, R.; Marx, N.; Rosenfeld, M.E.; Isermann, B.; Weber, C.M.; Kreuzer. J.; GräJ, Katus, H.A.; Bea, F. Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice. Atherosclerosis, 2008, 199, 295-303.
62. Morsy, M.A.; Ashour, O.M.; Fouad, A.A.; Abdel-Gaber, S.A. Gastroprotective effects of the insulin sensitizers, rosiglitazone and metformin, in indomethacin-induced gastric ulcer in type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol ., 2010, 37, 173-177.
63. Jung, K.H.; Chu, K.; Lee, S.T.; Kim. S.J.; Song, E.C.; Kim, E.H.; Park, D.K.; Sinn, D.I.; Kim, J.M.; Kim, M.; Roh, J.K. Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage. J. Pharmacol. Exp. Ther., 2007, 322, 1051-1058. (Pubitemid 47295814)
64. Kaschina, E.; Schrader, F.; Sommerfeld, M.; Kemnitz, U.R.; Grzesiak, A.; Krikov, M.; Unger, T. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation. J. Hypertens., 2008, 26, 2361-2373.
65. Hallersund, P.; Helander, H.F.; Casselbrant, A.; Edebo, A.; Fandriks, L.; Elfvin, A. Angiotensin II receptor expression and relation to Helicobacter pylori-infection in the stomach of the Mongolian gerbil. BMC Gastroenterol., 2010, 10, 3.
66. Hallersund, P.; Elfvin, A.; Helander, H.F.; Fasidriks, L. The expression of rennin -angiotensin system components in the human gastric mucosa. J. Renin. Ang. Aldost. Syst., 2010, 12, 54-64.
67. Rasini, E.; Cosentino, M.; Marino, F.; Legnaro, M.; Ferrari, M.; Guasti, L.; Venco, A.; Lecchini, S. Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. Regul. Pept., 2006, 134, 2-3, 69-74.
68. Elfvin, A.; Edebo, A.; Bolin, I.; Fandriks, L. Quantitative measurement of nitric oxide and hydrogen peroxide in Helicobacter pylori-infected Mongolian gerbils in vivo. Scand. J. Gastroenterol., 2007, 42, 10, 1175-1181. (Pubitemid 47537080)
69. Huang, W.; Yu, L.F.; Zhong, J. et al. Stat3 is involved in angiotensin IIinduced expression of MMP2 in gastric cancer cells. Dig. Dis. Sci ., 2009, 54, 2056-2062
70. Sugimoto, M.; Furuta, T.; Shirai, N. et al. Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in Japanese. Carcinogenesis, 2007, 28, 2036-2040. (Pubitemid 47500620)
71. Soares de Moura, R.; Resende, A.C.; Emiliano, A.F.; et. al. The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF -dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat. Br. J. Pharmacol., 2004, 141, 860-6. (Pubitemid 38446187)
72. Cosentino, F.; Savoia, C.; De Paolis, P. et. al. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type I receptor antagonists. Am. J. Hypertens., 2005, 18, 493-9.
73. You, D.; Loufrani, L.; Baron, C.; Levy, B.I.; Widdop, R.E.; Henrion, D. High blood pressure reduction reverses angiotensin II type 2 receptor -mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation, 2005, 111, 1006-11. (Pubitemid 40354518)
74. Meng, W.; Busija, D.W. Comparative effects of angiotensin -(1-7) and angiotensin II on piglet pial arterioles. Stroke, 1993, 24, 2041-4.
75. Ren, Y.; Garvin, J.L.; Carretero, O.A. The vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension, 2002, 39, 799-802. (Pubitemid 34252879)
76. Santos, R.A.; Simoes e Silva, A.C.; Maric, C. et. al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl Acad. Sci., 2003, 100, 8258-63. (Pubitemid 36842532)
77. Oliveira, M.A.; Fortes, Z.B.; Santos, R.A.; Kosla, M.C.; De Carvalho, M.H. Synergistic effect of angiotensin (1-7) on bradykinin arteriolar dilation in vivo. Peptides, 1999, 20, 1195-201. (Pubitemid 29512440)
78. Bernstein, K.E. Views of the renin-angiotensin system: brilling, mimsy, and slithy tove. Hypertension, 2006, 47,3, 509-514. (Pubitemid 43843867)
79. Ferrario, C.M.; Chappell, M.C. Novel angiotensin peptides. Cell. Mol. Life Sci., 2004, 61,21, 2720-2727. (Pubitemid 40022433)
80. Varagic, J.; Trask, A.J.; Jessup, J.A.; Chappell, M.C.; Ferrario, C.M. New angiotensins. J. Mol. Med., 2008, 86,6, 663-671.
81. Kramkowski, K., Mogielnicki, A., Buczko, W. The physiological significance of the alternative pathways of angiotensin II production. J. Physiol. Pharmacol., 2006, 57,4, 529-539. (Pubitemid 46096103)
82. Miyazaki, M.; Takai, S. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J. Pharmacol Sci., 2006, 100,5, 391-397. (Pubitemid 44609530)
83. Wolf, G. Novel aspects of the renin-angiotensin-aldosteronesystem. Front. Biosci., 2008, 13, 4993-5005.
84. Nonotte, I.; Laliberte, M.F.; Duperray, C.; Hollande, F.; Bali, J.P.; Laliberte, F. et al. Expression of angiotensin I converting enzyme mRNA in rabbit gastric epithelial cells. Mol. Cell Endocrino.,l 1993, 92,2,167-174. (Pubitemid 23124979)
85. Pawlik, M.W.; Sendur, R.; Biernat, J.; Brzozowski, T.; Konturek, S.; Pawlik W.W. Involvement of nitric oxide and prostaglandins in the angiotensin 1-7 induced acceleration of the healing of experimental gastric ulcers. Gastroenterology, 2010, 138, 5, 1, S131.
86. Cullen, J.J.; Ephgrave, K.S.; Kleiman-Wexler, R.L.; Broadhurst, K. Angiotensin-converting enzyme inhibition, kinins, and stress ulceration. Cur. Surg. 1990, 47,6, 452-454.
87. Ender, F.; Labancz, T.; Rosivall, L. Protective effects of the inhibition of the renin-angiotensin system against gastric mucosal lesions induced by coldrestraint in the rat. Acta Physiol. Hung., 1993, 81,1,13-18. (Pubitemid 24087353)
88. Kincaid, E.H.; Miller, P.R.; Meredith, J.W.; Chang, M.C. Enalaprilat improves gut perfusion in critically injured patients. Shock, 1998, 9,2, 79-83. (Pubitemid 128464315)
89. Nonotte, I.; Laliberte, M.F.; Gannoun-Zaki, L.; Bali, J.P.; Chevillard, C.; Laliberte, F. Localization of angiotensin converting enzyme (ACE) mRNA in rabbit gastric mucosa by in situ hybridization. J. Histochem. Cytochem., 1994, 42,2,197-201. (Pubitemid 24042236)
90. Bujak-Gizycka, B.; Madej, J.; Wolkow, P.P.; Olszanecki, R.; Drabik, L.; Rutowski, J. et al. Measurement of angiotensin metabolites in organ bath and cell culture experiments by liquid chromatography -electrospray ionization -mass spectrometry (LC-ESI-MS). J. Physiol. Pharmacol., 2007, 58,3, 529-540. (Pubitemid 47523095)
91. Olszanecki, R.; Bujak-Gizycka, B.; Madej, J.; Suski, M.; Wolkow, P.P.; Jawien, J. et al. Kaempferol, but not resveratrol inhibits angiotensin converting enzyme. J. Physiol. Pharmacol., 2008; 59,2, 387-392. (Pubitemid 351955760)
92. Mise, S.; Tonkic, A.; Pesutic, V.; Tonkic, M; Capkun, V.; Batelja, L.; Blagaic, AB.; Kokic, N.; Zoricic, I.; Seifert, D.; Anic, T.; Seiwerth, S.; Sikiric, P. The presentation and organization of adaptive cytoprotection in the rat stomach, duodenum, and colon. Dedicated to André Robert the founder of the concept of cytoprotection and adaptive cytoprotection. Med Sci Monit., 2006, 12, BR146-53.
93. Bedekovic, V.; Mise, S.; Anic, T.; Staresinic, M.; Gjurasin, M.; Kopljar, M.; Kalogjera, L.; Davis, P.; Blagaic, A.; Batelja, L.; Seiwerth, S.; Sikiric, P. Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy. Eur J Pharmacol., 2003, 47, 73-80. (Pubitemid 38366088)
94. Haulica, I.; Bild, W.; Serban, D.N. Angiotensin peptides and their pleiotropic actions. J. Renin. Angiotensin. Aldosterone. Syst., 2005; 6,3, 121-131. (Pubitemid 43263350)
95. Chappel, M.C.; Ferrario, C.M. ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7). Kidney Int., 2006, 70,1, 8-10. (Pubitemid 44000112)
96. Chappell, M.C. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? Hypertension, 2007, 50,4, 596-599. (Pubitemid 47442717)